Hsbc Holdings PLC Amgen Inc Put Options Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

Put Options

30 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $4.95 Million - $5.4 Million	16,000 Added 115.94%	29,800 $9.6 Million
Q2 2024 Aug 12, 2024	SELL	$262.75 - $319.31 $5.62 Million - $6.83 Million	-21,400 Reduced 60.8%	13,800 $4.31 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $22.3 Million - $27 Million	-83,100 Reduced 70.25%	35,200 $10 Million
Q4 2023 Feb 12, 2024	BUY	$255.7 - $288.46 $13 Million - $14.7 Million	50,800 Added 75.26%	118,300 $34.1 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $284,245 - $352,898	1,300 Added 1.96%	67,500 $18.1 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $2.55 Million - $3.02 Million	-11,900 Reduced 15.24%	66,200 $14.7 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $19.1 Million - $23.3 Million	-84,700 Reduced 52.03%	78,100 $18.9 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $5.61 Million - $7.13 Million	24,500 Added 17.72%	162,800 $42.8 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $8.01 Million - $9.04 Million	35,700 Added 34.8%	138,300 $31.4 Million
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $12.4 Million - $13.8 Million	53,800 Added 110.25%	102,600 $25 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $5.5 Million - $6.09 Million	25,100 Added 105.91%	48,800 $11.9 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $1.03 Million - $1.18 Million	5,200 Added 28.11%	23,700 $5.33 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $891,534 - $1.04 Million	-4,200 Reduced 18.5%	18,500 $3.97 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $1.24 Million - $1.37 Million	-5,300 Reduced 18.93%	22,700 $5.53 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $13.4 Million - $15.6 Million	-60,200 Reduced 68.25%	28,000 $6.97 Million
Q4 2020 Feb 25, 2021	BUY	$216.38 - $257.67 $8.7 Million - $10.4 Million	40,230 Added 83.86%	88,200 $20.3 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $9.96 Million - $11.9 Million	-46,030 Reduced 48.97%	47,970 $11 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $4.6 Million - $5.11 Million	-19,600 Reduced 17.25%	94,000 $23.9 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $217,591 - $267,014	1,100 Added 0.98%	113,600 $26.8 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $12.4 Million - $16.4 Million	-68,000 Reduced 37.67%	112,500 $22.9 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $5.2 Million - $6.69 Million	-27,500 Reduced 13.22%	180,500 $43.3 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $4.27 Million - $5.11 Million	24,500 Added 13.35%	208,000 $40.3 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $10.9 Million - $12.8 Million	-65,400 Reduced 26.28%	183,500 $33.8 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $24.1 Million - $27.2 Million	-133,200 Reduced 34.86%	248,900 $47.3 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $5.92 Million - $6.91 Million	33,200 Added 9.52%	382,100 $74.4 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $14.2 Million - $16 Million	76,600 Added 28.13%	348,900 $72.3 Million
Q2 2018 Aug 10, 2018	BUY	$166.05 - $186.51 $2.14 Million - $2.41 Million	12,900 Added 4.97%	272,300 $50.3 Million
Q1 2018 May 11, 2018	BUY	$169.43 - $198.0 $9.37 Million - $10.9 Million	55,300 Added 27.09%	259,400 $44.2 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $4.23 Million - $4.83 Million	25,300 Added 14.15%	204,100 $38.1 Million
Q2 2017 Aug 14, 2017	BUY	N/A	178,800	178,800 $30.8 Million

Others Institutions Holding AMGN

# of Institutions

3,113

Shares Held

410M

Call Options Held

Put Options Held

6.15M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account